title: Is intravenous thrombolysis feasible in a developing country?
authors: Stroke Unit, Department of Neurology, Christian Medical College, Ludhiana, India. jeyarajpandian@yahoo.co.in
authors: Jeyaraj Durai
authors: JD
authors: Pandian
authors: Vineeta
authors: V
authors: Sethi
authors: Robinderjeet
authors: R
authors: Dhillon
authors: Ravneet
authors: R
authors: Kaur
authors: Smita
authors: S
authors: Padala
authors: Rajesh
authors: R
authors: Chakravorty
authors: Yashpal
authors: Y
authors: Singh
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D003906:Developing Countries; D005006:Ethnicity; D006801:Humans; D008875:Middle Aged; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012737:Sex Factors; D012959:Socioeconomic Factors; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator